IDC: in the second quarter, the mobile phone market in India accounted for 35.5% of the total market share of Samsung mobile phones

According to the latest data from IDC, Samsung regained the top position in the Indian mobile phone market in the second quarter from April to June this year, surpassing China’s Xiaomi and vivo. < / P > < p > in India, Samsung has a 24% share of the functional plus smartphone market, followed by Xiaomi and vivo, but the latter two currently only sell smartphones in India. Xiaomi ranks first in the smartphone market, but Samsung has narrowed the gap, accounting for 26.3% of the smartphone market in the quarter ending June, compared with 15.6% in the previous quarter. Xiaomi and vivo had 29.4% and 17.5% of the smartphone market at the end of the quarter, respectively. However, navekender Singh, director of India research at IDC, said Samsung’s leading position may be temporary. “Samsung’s market share growth in the past quarter was mainly due to the shortage of inventory of domestic manufacturers in China, as well as minor emotions. If it wasn’t for the new coronavirus and supply chain problems, vivo should be the second place in the overall market. ” < / P > < p > according to it home, in the second quarter of 2020, the overall millet shipment decreased by 48.7% to 5.4 million units. In the fourth place, realme’s shipment volume in the second quarter of 20 was 1.78 million units, down 37% year-on-year. Oppo, which ranked fifth, saw a 51% year-on-year drop in shipments in the second quarter to 1.76 million units. IDC said India’s smartphone market recorded a sharp year-on-year decline of 50.6% in the second quarter of 2020, from 36.8 million a year ago to 18.2 million. IDC expects the market to show signs of recovery in the second half of 2020. In the second quarter, the volume of functional mobile phones decreased by 69% to 10 million units year-on-year, resulting in a 35.5% contribution rate to India’s overall mobile market, the lowest ever in the field. American companies begin to give up R & D: who should pay for corporate research?